Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome
- PMID: 16501775
- DOI: 10.1590/s0037-86822006000100018
Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome
Abstract
We report a case of cerebral meningoencephalitis due to Trypanosoma cruzi in a patient with acquired immunodeficiency syndrome. The patient presented with seizures and focal neurological signs. Definitive diagnosis of chagasic meningoencephalitis was made by demonstration of free trypomastigote forms in the cerebrospinal fluid. Benznidazol was prescribed with clinical and neurological improvement. Antiretroviral drugs improved cellular immunity and three years later the patient presents a good clinical condition with immune reconstitution and undetectable viral load. Chagasic meningoencephalitis has a poor prognosis when specific treatment is not initiated or is delayed. A high index of diagnosis is necessary for early diagnosis and treatment, especially in endemic areas for Trypanosoma cruzi infection.
Similar articles
-
Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil.Rev Inst Med Trop Sao Paulo. 2004 Jul-Aug;46(4):199-202. doi: 10.1590/s0036-46652004000400005. Epub 2004 Sep 3. Rev Inst Med Trop Sao Paulo. 2004. PMID: 15361971
-
Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome.Am J Trop Med Hyg. 2014 Jul;91(1):84-5. doi: 10.4269/ajtmh.14-0058. Epub 2014 Jun 2. Am J Trop Med Hyg. 2014. PMID: 24891470 Free PMC article.
-
CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.Rev Inst Med Trop Sao Paulo. 2015 Dec;57(6):531-5. doi: 10.1590/S0036-46652015000600014. Rev Inst Med Trop Sao Paulo. 2015. PMID: 27049711 Free PMC article.
-
Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association.Lancet Infect Dis. 2009 May;9(5):324-30. doi: 10.1016/S1473-3099(09)70088-X. Lancet Infect Dis. 2009. PMID: 19393962 Review.
-
Trypanosoma cruzi meningoencephalitis in HIV-infected patients.J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):342-9. doi: 10.1097/00042560-199904010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1999. PMID: 10096578 Review.
Cited by
-
Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.Indian J Med Res. 2011 Dec;134(6):878-97. doi: 10.4103/0971-5916.92633. Indian J Med Res. 2011. PMID: 22310820 Free PMC article. Review.
-
Acute chagas disease: new global challenges for an old neglected disease.PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3010. doi: 10.1371/journal.pntd.0003010. eCollection 2014. PLoS Negl Trop Dis. 2014. PMID: 25077613 Free PMC article. Review.
-
Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.PLoS Negl Trop Dis. 2016 Feb 26;10(2):e0004407. doi: 10.1371/journal.pntd.0004407. eCollection 2016 Feb. PLoS Negl Trop Dis. 2016. PMID: 26919324 Free PMC article.
-
A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.Antimicrob Agents Chemother. 2007 Nov;51(11):3932-9. doi: 10.1128/AAC.00436-07. Epub 2007 Aug 13. Antimicrob Agents Chemother. 2007. PMID: 17698625 Free PMC article.
-
In vitro Leishmanicidal and Trypanosomicidal Properties of Imidazole-Containing Azine and Benzoazine Derivatives.ChemMedChem. 2021 Dec 6;16(23):3600-3614. doi: 10.1002/cmdc.202100413. Epub 2021 Oct 19. ChemMedChem. 2021. PMID: 34665510 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical